Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein

Simon Mead1, Jonathan D F Wadsworth2, Marie-Claire Porter3

  • 1National Prion Clinic, National Hospital for Neurology and Neurosurgery, Queen Square, London, England2Medical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, En.

JAMA Neurology
|January 22, 2014
PubMed
Abstract

Insights

Variant Creutzfeldt-Jakob disease (vCJD) can present with minimal prion protein in peripheral tissues and blood. This challenges current diagnostic methods and prevalence studies for vCJD in the UK population.

Area of Science:

  • Neurodegenerative diseases
  • Prion diseases
  • Epidemiology

Background:

  • Bovine spongiform encephalopathy (BSE) transmission to humans causes variant Creutzfeldt-Jakob disease (vCJD).
  • vCJD is a fatal neurodegenerative condition primarily affecting young adults in the UK.
  • Prevalence studies suggest widespread subclinical prion infection in the UK population.

Observation:

  • A case of vCJD in the UK is presented with typical clinical progression.
  • Minimal prion protein deposition was found in peripheral lymphoreticular tissue.
  • A blood test for vCJD yielded a negative result.

Findings:

  • Some vCJD patients exhibit very low peripheral prion colonization.
  • Diagnostic tonsillar biopsy may not detect prion deposition in these cases.
  • Blood markers for prion infection may be absent.

Implications:

  • Diagnostic test interpretation for vCJD requires careful consideration of prion distribution.
  • Prevalence studies relying on lymphoreticular tissue or blood may underestimate vCJD infection rates.
  • Further research is needed to refine vCJD diagnostic strategies and epidemiological assessments.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
933
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110